Malini Raghavan, PhD
Department of Microbiology and Immunology
6706 Medical Science Building II
Ann Arbor, Michigan 48109
[email protected]

Available to mentor

Malini Raghavan, PhD
Professor
  • Qualifications
  • Center Memberships
  • Research Overview
  • Links
  • Recent Publications
  • Qualifications
    • Post-doctoral Fellowship
      California Institute of Technology, Division of Biology, 1996
    • PhD
      Princeton University, Princeton, 1991
    • MS
      Indian Institute of Technology, Kanpur, 1985
    • BSc
      Women's Christian College, Madras, 1983
    Center Memberships
    • Center Member
      Rogel Cancer Center
    Research Overview

    Human Leukocyte Antigen class I (HLA-I) Polymorphisms & their Influences on Immunity
    Cell Transformation and Immunity in Myleoproliferative Neoplasms
    Breadth of Cytotoxic T cell responses following COVID-19 Vaccination

    Links
    • Raghavan Lab
    Recent Publications See All Publications
    • Journal Article
      Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer.
      Jiang CY, Zhao L, Green MD, Ravishankar S, Towlerton AMH, Scott AJ, Raghavan M, Cusick MF, Warren EH, Ramnath N. Sci Rep, 2024 Jan 3; 14 (1): 345 DOI:10.1038/s41598-023-48546-y
      PMID: 38172168
    • Journal Article
      Mass Spectrometric Profiling of HLA-B44 Peptidomes Provides Evidence for Tapasin-Mediated Tryptophan Editing.
      Kaur A, Surnilla A, Zaitouna AJ, Mumphrey MB, Basrur V, Grigorova I, Cieslik M, Carrington M, Nesvizhskii AI, Raghavan M. J Immunol, 2023 Nov 1; 211 (9): 1298 - 1307. DOI:10.4049/jimmunol.2300232
      PMID: 37737643
    • Journal Article
      Major histocompatibility complex class I assembly within endolysosomal pathways.
      Olson E, Raghavan M. Curr Opin Immunol, 2023 Oct; 84: 102356 DOI:10.1016/j.coi.2023.102356
      PMID: 37379719
    • Journal Article
      Structural Modeling of Cytokine-Receptor-JAK2 Signaling Complexes Using AlphaFold Multimer.
      Pogozheva ID, Cherepanov S, Park S-J, Raghavan M, Im W, Lomize AL. J Chem Inf Model, 2023 Sep 25; 63 (18): 5874 - 5895. DOI:10.1021/acs.jcim.3c00926
      PMID: 37694948
    • Journal Article
      Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors.
      Mumphrey MB, Hosseini N, Parolia A, Geng J, Zou W, Raghavan M, Chinnaiyan A, Cieslik M. Cell Rep, 2023 Aug 29; 42 (8): 112965 DOI:10.1016/j.celrep.2023.112965
      PMID: 37597185
    • Preprint
      Lysosomal Degradation Pathways Target Mutant Calreticulin and the Thrombopoietin Receptor in Myeloproliferative Neoplasms
      Kaur A, Venkatesan A, Kandarpa M, Talpaz M, Raghavan M. 2023 bioRxiv, DOI:10.1101/2023.07.12.548605
    • Preprint
      Structural modeling of cytokine-receptor-JAK2 signaling complexes using AlphaFold Multimer.
      Pogozheva ID, Cherepanov S, Park S-J, Raghavan M, Im W, Lomize AL. 2023 Jun 14; DOI:10.1101/2023.06.14.544971
      PMID: 37398331
    • Proceeding / Abstract / Poster
      Role of HLA-DRB4 as a biomarker for endocrine toxicity and survival outcomes after immunotherapy in metastatic non-small cell lung cancer.
      Jiang C, Ravishankar S, Zhao L, Green M, Towlerton A, Scott A, Raghavan M, Cusick M, Warren EH, Ramnath N. Journal of Clinical Oncology, 2023 Jun 1; 41 (16_suppl): e21005 - e21005. DOI:10.1200/jco.2023.41.16_suppl.e21005
    Featured News & Stories
    Department News
    Dr. Malini Raghavan named the Nancy Williams Walls Research Professor
    Dr. Malini Raghavan named the Nancy Williams Walls Research Professor